Onkologische Schwerpunktpraxis Speyer
- Address
- lock Available on a paid plan
Onkologische Schwerpunktpraxis Speyer
Onkologische Schwerpunktpraxis Speyer is a specialized oncology center dedicated to advancing cancer treatment through cutting-edge clinical research. The center focuses on gastrointestinal malignancies and innovative therapeutic approaches for complex oncological conditions.
- Gastric and gastroesophageal junction adenocarcinoma research
- Hyperthermic intraperitoneal chemotherapy (HIPEC) protocols
- Perioperative chemotherapy strategies for resectable tumors
The practice participates in progressive clinical trials evaluating novel treatment combinations for diffuse type gastric cancer, with particular emphasis on disease-free survival outcomes. Their research portfolio includes the PREVENT trial, which investigates the role of HIPEC in combination with systemic chemotherapy regimens for patients with resectable gastroesophageal junction adenocarcinoma.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 26 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Onkologische Schwerpunktpraxis Speyer
lock Showing 1 of 10 trials — the rest is available on a paid plan.
IMP list
lock Showing 1 of 26 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capecitabine | 4 | Unknown | 2019-12-04 | 2025-04-01 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.